GMT EIGHT - IPO - Hong Kong

New stock news | Henmi Pharmaceutical plans to list in Hong Kong. The China Securities Regulatory Commission requires further clarification on the detailed situation of the previous A-share listing guidance filing.

In the announcement, the China Securities Regulatory Commission requires Hemei Pharmaceutical to provide detailed information about the previous A-share listing counseling filing, whether it plans to continue with the A-share listing and the specific arrangements, and whether there are any significant impacts on this issuance and listing.

New Stock News | Huanshi Logistics Plans to List in Hong Kong. The China Securities Regulatory Commission requires additional clarification on the reasons for the three capital reductions during the adjustment of the equity structure and the situation of price payment.

In the announcement, the Securities Regulatory Commission requires Huan Shi Logistics to provide further explanations on the reasons for the three capital reductions during the adjustment of the equity structure and the payment of consideration, whether there is any involvement of false capital contribution or unauthorized withdrawal of capital. It should also explain the performance of the relevant decision-making procedures and the payment of taxes and fees, and whether it complies with the Company Law and relevant tax laws and regulations.

New Stock News | Riyo Corporation plans to list in Hong Kong. The China Securities Regulatory Commission requires supplementary information on the compliance of the implemented stock incentive plan, among other things.

The China Securities Regulatory Commission requires RiYi Shares to provide additional explanation on the reasonableness of the price at which new shareholders have entered in the past 12 months, and the compliance of the implemented equity incentive plan.

New Stock News | Yushui Technology plans to list on the Hong Kong stock market. The China Securities Regulatory Commission requires additional clarifications on the compliance of the implemented equity incentive plan and other matters.

The China Securities Regulatory Commission requires Yushi Technology to provide further explanation on the compliance of the implemented equity incentive plan, the progress of state-owned shareholders in performing state-owned share labeling and other state-owned asset management procedures.

New Stock Preview | Lemo IoT: Smart Massage Chair Leader Successfully Listed Again, How to Break Through Growth Anxiety?

As a leading company in the field of shared intelligent massage chairs, Lemo IoT seems to be hinting at its future growth anxiety by reaching out to the Hong Kong market twice.

Accelerate the international innovation process to create a green aluminum industry group.

Since the beginning of the year, the hot trend of Hong Kong Stock Exchange listings continues to rise.

New stock news | Wangshan Wangshui submits secondary application to Hong Kong Stock Exchange, with a sharp drop in revenue and continued losses

According to the disclosure of the Hong Kong Stock Exchange on July 31st, Suzhou Wangshan Wangshui Biopharmaceutical Co., Ltd. (referred to as Wangshan Wangshui) has submitted an application to list on the main board of the Hong Kong Stock Exchange, with CITIC Securities as its sole sponsor.

New stock preview | Smart energy solution industry leader, Shengru Technology once again "listed"

The leading domestic smart energy solution, after experiencing a failure once, Shengrui Technology will once again fight for a listing on the Hong Kong stock exchange. Will they be able to get the green light from the Hong Kong Stock Exchange this time?

New stock preview | Positive holding: From "Inflammation off" to the capital market: The breakthrough and limitations of a Hong Kong health product leader.

The profit dilemma behind the high growth of genuine brand holding.

New Stock Preview| Will Wenzhen Traditional Chinese Medicine seize the opportunity in Hong Kong stocks, can the growth narrative of Traditional Chinese Medicine + AI support the facade?

As the scale steadily expands, investors may be concerned with whether Wenzhi Traditional Chinese Medicine can translate the economies of scale into sustainable profits, and this will likely become one of their core concerns.

New stock news | Danuo pharmaceutical company submits an application to the Hong Kong Stock Exchange, owning three core products including Lefortinib (TNP-2198)

According to the disclosure by the Hong Kong Stock Exchange on July 30, Dano Medicine (Suzhou) Co., Ltd. has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with China International Capital Corporation and Agricultural Bank of China International as the joint sponsors.

New Stock News | SICC Co., Ltd. (688234.SH) is the world's top three silicon carbide substrate manufacturer, and has passed the hearing at the Hong Kong Stock Exchange.

According to the data from Frost & Sullivan, based on the sales revenue of silicon carbide substrates in 2024, the company is one of the top three silicon carbide substrate manufacturers in the world, with a market share of 16.7%.

New stock news | Sunwoda Electronic (300207.SZ) submits listing application to the Hong Kong Stock Exchange, holding over 34% global market share in mobile phone batteries.

According to the disclosure on July 30 by the Hong Kong Stock Exchange, Xiwangda (300207.SZ) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with Goldman Sachs and Citic Securities serving as its joint sponsors.

New Stock News | Cloud Sky Inspire Flying (688343.SH) submits documents to Hong Kong Stock Exchange as a leading provider of full-scene AI inference chips in the industry.

According to the disclosure by the Hong Kong Stock Exchange on July 30th, Yun Tian Li Fei (688343.SH) has submitted a listing application to the main board of the Hong Kong Stock Exchange, with Huatai International, Citic Securities, and CICC International as its joint sponsors.

New Stock News | Guangdong Hec Technology Holding Medicine (06887) Completes Innovative Capital Operation on Hong Kong Stock Exchange Main Board and Will Land on August 7

Dongyang Guang Pharmaceutical (06887) has completed an innovative capital operation in the Hong Kong stock market and will officially debut on the main board of the Hong Kong Stock Exchange on August 7th.

New stock news | Wen Zhizhong Traditional Chinese Medicine once again submits an application to the Hong Kong Stock Exchange as the largest provider of artificial intelligence-assisted traditional Chinese medicine medical services in mainland China.

According to the disclosure by the Hong Kong Stock Exchange on July 29th, Wan Zhi Zhong Yi has submitted an application for listing on the Main Board of the Hong Kong Stock Exchange, with Haitong International as the exclusive sponsor.

New stock news | Authentic Holdings submits application to Hong Kong Stock Exchange to be listed in 2024 with the retail value of health supplements and products related to deer in Hong Kong ranking first.

The prospectus shows that Genuine Holdings is mainly engaged in the development, sales, marketing and distribution of health and beauty supplements and products in Hong Kong.

New Stock Outlook | Leading kaolin company Jinan High-tech Ventures to Hong Kong again: Net profit doubles on the left hand, while "begging for a gold bowl" on the right hand.

Jinyan High-tech is determined to take multiple actions to step onto a bigger capital stage, which may be related to the company's ambitious expansion plans.

New Stock Outlook|Tianyu Semiconductor's "Second Declaration": With the rapid development of the industry, what is the investment value of semiconductor "unicorns"?

As a rare semiconductor unicorn in the Greater Bay Area, many "big shots" are backing the investor lineup behind Tianyu Semiconductor.

New Stock Outlook | The core product is still in the early stages of research and development. How should we view the "golden content" of Yino Micro Medicine's pipeline?

With the recovery of market liquidity, the overlap of policy support and improvement of industry fundamentals, the prosperity of the innovative pharmaceutical sector is continuously increasing.

Seeking Coverage

Being Writer

Exploring Cooperation